Peptide Product Composition: How Glucagon Ensures Hormonal Balance
Abstract: Glucagon, a critical peptide hormone, ensures hormonal balance by counteracting insulin to regulate blood glucose. In the expanding peptide product market, glucagon-based compositions are pivotal for diabetes and metabolic disorder treatments. Current industry trends show a 12.5% CAGR (2024-2030), driven by advanced synthesis technologies. Leading brands (e.g., Novo Nordisk, Eli Lilly) demonstrate superior purity (>99%) and stability via HPLC validation, while smaller manufacturers often lack GMP certifications. Key selection criteria include third-party COA verification, lyophilized logistics (-20°C cold chain), and batch-to-batch consistency. This analysis compares product parameters, technical advantages (high specificity) and limitations (short half-life), guiding informed procurement for therapeutic efficacy.